was read the article
array:21 [ "pii" => "X2013251407020776" "issn" => "20132514" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2007-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2007;27:23-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2896 "formatos" => array:3 [ "EPUB" => 207 "HTML" => 1999 "PDF" => 690 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699507020779" "issn" => "02116995" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2007-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2007;27:23-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 13457 "formatos" => array:3 [ "EPUB" => 242 "HTML" => 12456 "PDF" => 759 ] ] "es" => array:11 [ "idiomaDefecto" => true "titulo" => "CONCENTRACIONES DE GLUTAMINA EN PACIENTES TRATADOS CON CISPLATINO PREDICEN EL DESARROLLO DE INSUFICIENCIA RENAL" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "23" "paginaFinal" => "29" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "GLUTAMIN LEVELS IN PATIENTS TREATED WITH CISPLATIN PREDICTS RENAL FAILURE" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho" "autores" => array:1 [ 0 => array:1 [ "nombre" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251407020776" "doi" => " " "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020776?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507020779?idApp=UINPBA000064" "url" => "/02116995/0000002700000001/v0_201502091327/X0211699507020779/v0_201502091327/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X2013251407020807" "issn" => "20132514" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2007-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2007;27:30-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3102 "formatos" => array:3 [ "EPUB" => 210 "HTML" => 1975 "PDF" => 917 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "USEFULNESS OF ORAL GLUCOSE TOLERANCE TEST (OGTT) IN OUTPUT PATIENTS WITH ADVANCED CHRONIC RENAL FAILURE (CRF)" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "30" "paginaFinal" => "37" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "IMPORTANCIA DEL TEST DE SOBRECARGA ORAL A LA GLUCOSA (TSOG) EN UNA CONSULTA ESPECÍFICA DE IRC AVANZADA ESTADIO IV Y V." ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Margarita Rufino Nefrología Hospital Universitario de Canarias, Pablo Barbero Nefrlogía Hospital Universitario de Canarias, Domingo Hernández Nefrolog" "autores" => array:1 [ 0 => array:1 [ "nombre" => "Margarita Rufino Nefrología Hospital Universitario de Canarias, Pablo Barbero Nefrlogía Hospital Universitario de Canarias, Domingo Hernández Nefrolog" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X021169950702080X" "doi" => " " "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X021169950702080X?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020807?idApp=UINPBA000064" "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020807/v0_201502091552/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251407020823" "issn" => "20132514" "doi" => " " "estado" => "S300" "fechaPublicacion" => "2007-02-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2007;27:12-22" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3199 "formatos" => array:3 [ "EPUB" => 202 "HTML" => 2186 "PDF" => 811 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "INTRAVENOUS CYCLOPHOSPHAMIDE IN LUPUS NEPHRITIS: TWENTY YEARS REDUCING DOSE" "tienePdf" => "en" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "12" "paginaFinal" => "22" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "CICLOFOSFAMIDA INTRAVENOSA EN NEFRITIS LUPICA: VEINTE AÑOS REDUCIENDO DOSIS" ] ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Miguel Angel Frutos Nefrologia Hospital Universitario Carlos Haya, Adoración Martin-Gomez Nefrologia Hospital Universitario Carlos Haya, Enrique De Ra" "autores" => array:1 [ 0 => array:1 [ "nombre" => "Miguel Angel Frutos Nefrologia Hospital Universitario Carlos Haya, Adoración Martin-Gomez Nefrologia Hospital Universitario Carlos Haya, Enrique De Ra" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699507020826" "doi" => " " "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699507020826?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020823?idApp=UINPBA000064" "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020823/v0_201502091552/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "GLUTAMIN LEVELS IN PATIENTS TREATED WITH CISPLATIN PREDICTS RENAL FAILURE" "tieneTextoCompleto" => 0 "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "23" "paginaFinal" => "29" ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho" "autores" => array:1 [ 0 => array:1 [ "nombre" => "M Cobo Oncologia Medica Hospital Universitario carlos Haya, M.A. Martin-Gomez Nefrologia Hospital Universitario carlos Haya, M.A. Frutos Nefrologia Ho" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "CONCENTRACIONES DE GLUTAMINA EN PACIENTES TRATADOS CON CISPLATINO PREDICEN EL DESARROLLO DE INSUFICIENCIA RENAL" ] ] "pdfFichero" => "P-E-S-A4333-EN.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec436396" "palabras" => array:4 [ 0 => "Aminoácidos" 1 => "Glutamina" 2 => "Insuficiencia renal" 3 => "Cisplatino" ] ] ] "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec436397" "palabras" => array:4 [ 0 => "Amino acids" 1 => "Glutamin" 2 => "Renal failure" 3 => "Cisplatin" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:1 [ "resumen" => "Glutamine is an amino acid (AA) whose mission is carrying nitrogen. Abnormalities in protein and AA metabolism has been observed in patients with acute renal failure. Several clinical trials had showed abnormalities in plasma AA and its elimination in uremic environment. Moreover, renal failure disturbs hepato-splachnic circulation of glutamin, tyrosine and proline. Cisplatin is a key drug in the chemotherapy pharmacology, and the nephrotoxicity due to tubular injury, is one of its most important side effects, which sometimes is irreversible and leads to substitutive renal treatment. The goal of this work is to find predictive factors of renal failure secondary to cisplatin. Fifty four patients treated with cisplatin were studied. The plasma AA concentration and another plasmatic and urine parameters were measured in three different days after each pulse of chemotherapy. Plasma AA modifications through the pulses and reabsortion percentages of everyone were analysed too. Significant differences were observed in 13 AA reabsortion percentages and 16 plasmatic concentration. Glutamin concentration through the pulses was higher in 13 patients, (24%) who presented renal failure (Plasmatic glutamin concentration higher than 1000 mM/L at the third day after cisplatin administration was highly predictive value about getting renal failure, with significant difference from patients with o normal renal function. Others parameters analysed did not rise significant predictive values, so as it was not found relation between hyperaminoaciduria and renal function. It is concluded that cisplatin leads to renal failure in a 24% of this patients. Glutamin, concentrations higher than 1000 mM/L at the third day after cisplatin administration have a high predictive value about getting renal failure; so, it is suggested this could be a early marker of cisplatin nephrotoxicity before the serum creatinine is elevated, in order to get an early and suitable treatment of it. " ] "es" => array:1 [ "resumen" => "La glutamina es un aminoácido encargado del transporte sanguíneo de nitrógeno. En pacientes que desarrollan insuficiencia renal se ha detectado alteración de los niveles plasmáticos de aminoácidos (AA) y alteración en su excreción urinaria. El cisplatino es un fármaco utilizado en quimioterapia, siendo la nefrotoxicidad uno de sus efectos secundarios más importantes. Con el objetivo de encontrar factores predictivos para el desarrollo de insuficiencia renal secundaria al cisplatino, se estudiaron 54 pacientes con diversos tumores en tratamiento con cisplatino, cuantificándose la concentración de AA y otros parámetros bioquímicos en plasma y en orina de 24 horas en tres días diferentes tras cada ciclo de quimioterapia. Se analizaron las variaciones de los AA plasmáticos a lo largo de los distintos ciclos de cisplatino y los porcentajes de reabsorción de cada uno de ellos. Se detectaron diferencias significativas a través de los ciclos en el porcentaje de reabsorción de 13 AA y en las concentraciones plasmáticas de 16. La concentración de glutamina a lo largo de los ciclos fue mayor en pacientes que desarrollaron insuficiencia renal. El valor de glutamina sérica > 1000 mM/L analizada el tercer día tras la administración de cisplatino fue altamente predictivo de desarrollar insuficiencia renal, con una diferencia significativa respecto a los pacientes que no la desarrollan. Se concluye que concentraciones superiores a 1000 mM/L de glutamina plasmática al tercer día tras la administración de cisplatino tienen un alto valor predictivo respecto al desarrollo de insuficiencia renal aguda. " ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000002700000001/v0_201502091552/X2013251407020776/v0_201502091552/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002700000001/v0_201502091552/X2013251407020776/v0_201502091552/en/P-E-S-A4333-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251407020776?idApp=UINPBA000064" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 11 | 9 | 20 |
2024 October | 54 | 80 | 134 |
2024 September | 53 | 66 | 119 |
2024 August | 58 | 109 | 167 |
2024 July | 43 | 54 | 97 |
2024 June | 50 | 47 | 97 |
2024 May | 53 | 48 | 101 |
2024 April | 44 | 39 | 83 |
2024 March | 35 | 40 | 75 |
2024 February | 42 | 44 | 86 |
2024 January | 31 | 39 | 70 |
2023 December | 26 | 22 | 48 |
2023 November | 31 | 42 | 73 |
2023 October | 63 | 41 | 104 |
2023 September | 57 | 38 | 95 |
2023 August | 30 | 25 | 55 |
2023 July | 35 | 39 | 74 |
2023 June | 35 | 22 | 57 |
2023 May | 40 | 35 | 75 |
2023 April | 21 | 25 | 46 |
2023 March | 36 | 22 | 58 |
2023 February | 23 | 19 | 42 |
2023 January | 21 | 34 | 55 |
2022 December | 40 | 31 | 71 |
2022 November | 34 | 35 | 69 |
2022 October | 26 | 38 | 64 |
2022 September | 35 | 29 | 64 |
2022 August | 41 | 38 | 79 |
2022 July | 27 | 41 | 68 |
2022 June | 33 | 41 | 74 |
2022 May | 23 | 29 | 52 |
2022 April | 25 | 40 | 65 |
2022 March | 37 | 45 | 82 |
2022 February | 32 | 39 | 71 |
2022 January | 24 | 35 | 59 |
2021 December | 36 | 47 | 83 |
2021 November | 19 | 33 | 52 |
2021 October | 23 | 41 | 64 |
2021 September | 35 | 32 | 67 |
2021 August | 17 | 29 | 46 |
2021 July | 41 | 32 | 73 |
2021 June | 18 | 20 | 38 |
2021 May | 21 | 24 | 45 |
2021 April | 45 | 41 | 86 |
2021 March | 43 | 20 | 63 |
2021 February | 23 | 21 | 44 |
2021 January | 24 | 17 | 41 |
2020 December | 14 | 7 | 21 |
2020 November | 23 | 10 | 33 |
2020 October | 10 | 11 | 21 |
2020 September | 17 | 6 | 23 |
2020 August | 32 | 9 | 41 |
2020 July | 21 | 5 | 26 |
2020 June | 13 | 7 | 20 |
2020 May | 37 | 14 | 51 |
2020 April | 22 | 14 | 36 |
2020 March | 26 | 15 | 41 |
2020 February | 28 | 11 | 39 |
2020 January | 17 | 14 | 31 |
2019 December | 27 | 18 | 45 |
2019 November | 18 | 17 | 35 |
2019 October | 11 | 8 | 19 |
2019 September | 12 | 17 | 29 |
2019 August | 9 | 15 | 24 |
2019 July | 16 | 20 | 36 |
2019 June | 17 | 21 | 38 |
2019 May | 39 | 35 | 74 |
2019 April | 38 | 40 | 78 |
2019 March | 10 | 19 | 29 |
2019 February | 9 | 17 | 26 |
2019 January | 14 | 22 | 36 |
2018 December | 15 | 27 | 42 |
2018 November | 29 | 23 | 52 |
2018 October | 23 | 22 | 45 |
2018 September | 26 | 15 | 41 |
2018 August | 15 | 9 | 24 |
2018 July | 11 | 15 | 26 |
2018 June | 12 | 22 | 34 |
2018 May | 15 | 15 | 30 |
2018 April | 8 | 11 | 19 |
2018 March | 14 | 13 | 27 |
2018 February | 4 | 8 | 12 |
2018 January | 14 | 11 | 25 |
2017 December | 12 | 15 | 27 |
2017 November | 9 | 14 | 23 |
2017 October | 16 | 14 | 30 |
2017 September | 13 | 8 | 21 |
2017 August | 22 | 12 | 34 |
2017 July | 12 | 17 | 29 |
2017 June | 12 | 15 | 27 |
2017 May | 14 | 13 | 27 |
2017 April | 20 | 9 | 29 |
2017 March | 12 | 22 | 34 |
2017 February | 16 | 10 | 26 |
2017 January | 7 | 6 | 13 |
2016 December | 32 | 11 | 43 |
2016 November | 35 | 15 | 50 |
2016 October | 31 | 20 | 51 |
2016 September | 59 | 11 | 70 |
2016 August | 97 | 10 | 107 |
2016 July | 94 | 10 | 104 |
2016 June | 96 | 0 | 96 |
2016 May | 110 | 0 | 110 |
2016 April | 96 | 0 | 96 |
2016 March | 66 | 0 | 66 |
2016 February | 70 | 0 | 70 |
2016 January | 86 | 0 | 86 |
2015 December | 98 | 0 | 98 |
2015 November | 96 | 0 | 96 |
2015 October | 74 | 0 | 74 |
2015 September | 58 | 0 | 58 |
2015 August | 61 | 0 | 61 |
2015 July | 48 | 0 | 48 |
2015 June | 32 | 0 | 32 |
2015 May | 50 | 0 | 50 |
2015 April | 13 | 0 | 13 |